124 related articles for article (PubMed ID: 18025186)
1. Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T cells and increases their thymic output.
Bruinsma M; van Soest PL; Leenen PJ; Lambrecht BN; Cupedo T; Löwenberg B; Cornelissen JJ; Braakman E
J Immunol; 2007 Dec; 179(11):7424-30. PubMed ID: 18025186
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte growth factor improves allogeneic bone marrow engraftment through a CD4+Foxp3+ regulatory T cell-dependent mechanism.
Bruinsma M; van Soest PL; Leenen PJ; Löwenberg B; Cornelissen JJ; Braakman E
J Immunol; 2009 Jun; 182(12):7364-9. PubMed ID: 19494258
[TBL] [Abstract][Full Text] [Related]
3. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant.
Wang Y; Chen G; Qiao S; Ma X; Tang X; Sun A; Wu D
Leuk Lymphoma; 2011 Aug; 52(8):1556-66. PubMed ID: 21649545
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
Jenq RR; King CG; Volk C; Suh D; Smith OM; Rao UK; Yim NL; Holland AM; Lu SX; Zakrzewski JL; Goldberg GL; Diab A; Alpdogan O; Penack O; Na IK; Kappel LW; Wolchok JD; Houghton AN; Perales MA; van den Brink MR
Blood; 2009 Feb; 113(7):1574-80. PubMed ID: 19011222
[TBL] [Abstract][Full Text] [Related]
6. Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance.
Shimoda M; Mmanywa F; Joshi SK; Li T; Miyake K; Pihkala J; Abbas JA; Koni PA
J Immunol; 2006 Jun; 176(11):6503-11. PubMed ID: 16709807
[TBL] [Abstract][Full Text] [Related]
7. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
8. "Default" generation of neonatal regulatory T cells.
Wang G; Miyahara Y; Guo Z; Khattar M; Stepkowski SM; Chen W
J Immunol; 2010 Jul; 185(1):71-8. PubMed ID: 20498359
[TBL] [Abstract][Full Text] [Related]
9. A20 Restrains Thymic Regulatory T Cell Development.
Fischer JC; Otten V; Kober M; Drees C; Rosenbaum M; Schmickl M; Heidegger S; Beyaert R; van Loo G; Li XC; Peschel C; Schmidt-Supprian M; Haas T; Spoerl S; Poeck H
J Immunol; 2017 Oct; 199(7):2356-2365. PubMed ID: 28842469
[TBL] [Abstract][Full Text] [Related]
10. Recent thymic origin, differentiation, and turnover of regulatory T cells.
Mabarrack NH; Turner NL; Mayrhofer G
J Leukoc Biol; 2008 Nov; 84(5):1287-97. PubMed ID: 18682578
[TBL] [Abstract][Full Text] [Related]
11. High Thymic Output of Effector CD4
Zhao Y; Alard P; Kosiewicz MM
J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
[TBL] [Abstract][Full Text] [Related]
12. Epithelial and dendritic cells in the thymic medulla promote CD4+Foxp3+ regulatory T cell development via the CD27-CD70 pathway.
Coquet JM; Ribot JC; Bąbała N; Middendorp S; van der Horst G; Xiao Y; Neves JF; Fonseca-Pereira D; Jacobs H; Pennington DJ; Silva-Santos B; Borst J
J Exp Med; 2013 Apr; 210(4):715-28. PubMed ID: 23547099
[TBL] [Abstract][Full Text] [Related]
13. Thymic production of human FOXP3(+) regulatory T cells is stable but does not correlate with peripheral FOXP3 expression.
Tuovinen H; Laurinolli TT; Rossi LH; Pekkarinen PT; Mattila I; Arstila TP
Immunol Lett; 2008 May; 117(2):146-53. PubMed ID: 18321596
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice.
Suffner J; Hochweller K; Kühnle MC; Li X; Kroczek RA; Garbi N; Hämmerling GJ
J Immunol; 2010 Feb; 184(4):1810-20. PubMed ID: 20083650
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression.
Ugor E; Prenek L; Pap R; Berta G; Ernszt D; Najbauer J; Németh P; Boldizsár F; Berki T
Immunobiology; 2018; 223(4-5):422-431. PubMed ID: 29223294
[TBL] [Abstract][Full Text] [Related]
16. Insight into normal thymic activity by assessment of peripheral blood samples.
Machnes-Maayan D; Lev A; Katz U; Mishali D; Vardi A; Simon AJ; Somech R
Immunol Res; 2015 Mar; 61(3):198-205. PubMed ID: 25294167
[TBL] [Abstract][Full Text] [Related]
17. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
[TBL] [Abstract][Full Text] [Related]
19. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
20. The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases.
Zhang A; Qu Y; Zhang B; Zhang L; Zeng C; Peng J; Ji X; Hou M; Zhao Y
J Mol Med (Berl); 2007 Nov; 85(11):1263-70. PubMed ID: 17639287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]